Type 2 diabetes: open trials in Puerto Rico

15 open trials have a site in Puerto Rico. Registry data; only the trial team decides who can take part.

NCT06897475
A Study of LY3457263 Compared With Placebo in Participants With Type 2 Diabetes on a Stable Dose of Semaglutide or Tirzepatide
Trial Treatment · Phase 2 · Eli Lilly and Company
Centro de Endocrinologia Alcantara Gonzalez, Bayamón · Mgcendo Llc, San Juan
Registry updated 2026-11-04
NCT07282600
A Study of Eloralintide (LY3841136) in Participants With Obesity or Overweight, and Type 2 Diabetes
Trial Treatment · Phase 3 · Eli Lilly and Company
Centro de Endocrinologia y Nutricion, Caguas · Dorado Medical Complex, Dorado
Registry updated 2026-11-04
NCT07392190
A Study of Eloralintide (LY3841136) in Participants With Persistent Obesity Who Are Treated With a Weekly Incretin
Trial Treatment · Phase 3 · Eli Lilly and Company
Advanced Clinical Research, LLC, Bayamón · Isis Clinical Research Center, Guaynabo
Registry updated 2026-11-04
NCT07881458
A Study of EloraTZP in Adult Participants With Obesity or Overweight and Type 2 Diabetes
Trial Treatment · Phase 3 · Eli Lilly and Company
Latin Clinical Trial Center, San Juan
Registry updated 2026-11-04
NCT07783802
A Study of Clazakizumab (LY5724886) in Adults With Elevated hsCRP and at Increased Risk for Cardiovascular Event
Trial Treatment · Phase 2 · Eli Lilly and Company
Dorado Medical Complex, Dorado · Wellness clinical Research Vega Baja, Vega Baja
Registry updated 2026-11-03
NCT07881432
A Study of EloraTZP in Adult Participants With Obesity Without Type 2 Diabetes
Trial Treatment · Phase 3 · Eli Lilly and Company
Puerto Rico Medical Research, Ponce · CMRC Headlands, LLC, San Juan · Miralles Clinical Research, San Juan
Registry updated 2026-11-03
NCT07900633
A Study of Eloralintide (LY3841136) in Participants With Obesity or Overweight, Type 2 Diabetes, and Increased Cardiovascular Risk
Trial Treatment · Phase 3 · Eli Lilly and Company
Puerto Rico Health and Wellness Institute, Dorado · Puerto Rico Medical Research, Ponce · Mgcendo Llc, San Juan
Registry updated 2026-11-03
NCT07662109
A Phase III Study to Investigate the Efficacy and Safety of the Combination of Elecoglipron and Dapagliflozin in Adults With Type 2 Diabetes Mellitus
Trial Treatment · Phase 3 · AstraZeneca
San Juan
Registry updated 2026-10-30
NCT07064473
EASi-PROTKT™ - A Study to Test Vicadrostat (BI 690517) Taken Together With Empagliflozin in People With Type 2 Diabetes, High Blood Pressure, and Cardiovascular Disease
Trial Treatment · Phase 3 · Boehringer Ingelheim
Dorado Medical Complex, Dorado · Research and Cardiovascular Corporation, Ponce · Ponce School of Medicine/CAIMED Center, Ponce · GCM Medical Group, PSC, San Juan · FDI Clinical Research, San Juan · Latin Clinical Trial Center, San Juan
Registry updated 2026-10-28
NCT07748208
A Study Evaluating the Safety of Inavolisib and Fulvestrant With or Without Palbociclib in Participants With Advanced Breast Cancer (ABC) and Type 2 Diabetes
Trial Treatment · Phase 2 · Hoffmann-La Roche
Pan American Center for Oncology Trials, LLC, Dorado
Registry updated 2026-10-20
NCT07351058
A Clinical Study to Evaluate the Effects of Enicepatide (RO7795068) in Participants With Obesity or Overweight and Type 2 Diabetes
Trial Treatment · Phase 3 · Hoffmann-La Roche
FDI Clinical Research, San Juan
Registry updated 2026-10-13
NCT07684144
Extension Trial to Evaluate the Long-term Efficacy, Safety, and Tolerability of Maridebart Cafraglutide (MARITIME-2-EXTENSION)
Trial Treatment · Phase 3 · Amgen
Latin Clinical Trial Center, San Juan
Registry updated 2026-10-05
NCT07321886
A Study of Eloralintide (LY3841136) in Participants With Obesity, or Overweight Without Type 2 Diabetes
Trial Treatment · Phase 3 · Eli Lilly and Company
Puerto Rico Health and Wellness Institute, Dorado · Wellness clinical Research Vega Baja, Vega Baja
Registry updated 2026-09-22
NCT05962372
Culturally Adapted Dietary Clinical Trial in PR
Trial Treatment · Harvard School of Public Health (HSPH)
Puerto Rico Consortium for Clinical Investigation, San Juan
Registry updated 2026-07-28
NCT06251323
Implementing Scalable, PAtient-centered, Team-based, Technology-enabled Care for Adults With Type 2 Diabetes (iPATH)
Trial Treatment · Stanford University
Impactivo, LLC., San Juan
Registry updated 2026-05-01

All Type 2 diabetes trials and the map

This page is not medical advice. Talk to your doctor before contacting a trial.

Report an error